United Health Products, Inc. (UEEC)
OTCMKTS
· Delayed Price · Currency is USD
0.0555
+0.0005 (0.91%)
At close: Mar 6, 2026
United Health Products Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | - | - | - | 0.04 | 0 | 0 | Upgrade
|
| Revenue Growth (YoY) | - | - | - | 63459.32% | -90.82% | -86.95% | Upgrade
|
| Cost of Revenue | - | - | - | 0.02 | 0 | 0 | Upgrade
|
| Gross Profit | - | - | - | 0.02 | 0 | 0 | Upgrade
|
| Selling, General & Admin | 2.44 | 1.65 | 1.83 | 2.2 | 29.56 | 14.6 | Upgrade
|
| Research & Development | 0.33 | 0.36 | 0.6 | 0.62 | 0.24 | 0.25 | Upgrade
|
| Operating Expenses | 2.78 | 2.01 | 2.43 | 2.82 | 29.8 | 14.85 | Upgrade
|
| Operating Income | -2.78 | -2.01 | -2.43 | -2.8 | -29.8 | -14.85 | Upgrade
|
| Interest Expense | -0.17 | -0.11 | -0.12 | -0.08 | -0.62 | -0.55 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | 1.01 | - | - | Upgrade
|
| EBT Excluding Unusual Items | -2.95 | -2.12 | -2.54 | -1.87 | -30.42 | -15.39 | Upgrade
|
| Legal Settlements | - | - | - | 0.39 | 0.3 | - | Upgrade
|
| Other Unusual Items | - | 0.12 | -0.08 | -0.21 | -0.43 | -0.32 | Upgrade
|
| Pretax Income | -2.95 | -2 | -2.62 | -1.69 | -30.55 | -15.71 | Upgrade
|
| Net Income | -2.95 | -2 | -2.62 | -1.69 | -30.55 | -15.71 | Upgrade
|
| Net Income to Common | -2.95 | -2 | -2.62 | -1.69 | -30.55 | -15.71 | Upgrade
|
| Shares Outstanding (Basic) | 255 | 248 | 239 | 230 | 226 | 184 | Upgrade
|
| Shares Outstanding (Diluted) | 255 | 248 | 239 | 230 | 226 | 184 | Upgrade
|
| Shares Change (YoY) | 3.50% | 3.80% | 4.08% | 1.76% | 22.85% | 4.48% | Upgrade
|
| EPS (Basic) | -0.01 | -0.01 | -0.01 | -0.01 | -0.14 | -0.09 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.01 | -0.01 | -0.01 | -0.14 | -0.09 | Upgrade
|
| Free Cash Flow | -0.82 | -1.19 | -2.2 | -0.62 | -0.83 | -1.43 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.01 | -0.01 | -0.00 | -0.00 | -0.01 | Upgrade
|
| Gross Margin | - | - | - | 50.28% | 57.63% | 69.67% | Upgrade
|
| Operating Margin | - | - | - | -7472.10% | -50509550.85% | -2309276.98% | Upgrade
|
| Profit Margin | - | - | - | -4500.00% | -51778276.27% | -2443452.57% | Upgrade
|
| Free Cash Flow Margin | - | - | - | -1652.59% | -1403523.73% | -221961.43% | Upgrade
|
| EBITDA | -2.77 | -2 | -2.42 | -2.8 | - | - | Upgrade
|
| D&A For EBITDA | 0 | 0 | 0 | 0 | - | - | Upgrade
|
| EBIT | -2.78 | -2.01 | -2.43 | -2.8 | -29.8 | -14.85 | Upgrade
|
| Advertising Expenses | - | - | - | - | 0.17 | 0.21 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.